Goodrx Aims To Regain Customers As The Demand For Cost Relief Increases

10
B2B

The pharmaceutical pricing comparison website GoodRx stated it was pivoting to regain lost sales and customers after a costly fight with a grocery chain’s pharmacy was settled, while it noted the process would take some time to complete.

In its announcement of its second-quarter earnings results and a cautious full-year outlook, the California-based company said its mission to provide Americans with affordable healthcare through its subscription-based price discounting was still very much intact because both its sales and subscriber base increased despite the grocer’s disruption.

According to Voermann, communication changes take time to trickle down to the pharmacy and retail levels. Uncertainty exists around the number of GoodRx customers who switched to their insurance or another sort of food savings during the second quarter, as well as the speed at which they might do so.

How Digital Is Moving

Despite this warning comment and modest sales predictions, investors were ecstatic with the settlement and propelled shares of GoodRx up as much as 50% in after-hours trade on Monday and over 20% in early trading on Tuesday.

Trevor Bezdek, co-founder and co-CEO of GoodRx, claims that the company is putting a high priority on developing new services and product improvements that will enable members to save money on healthcare in more ways while allowing the company to “increase its touchpoints” and take a more active role in all facets of customers’ care in order to speed up that rebound. Bezdek claims that GoodRx is likewise attempting to stabilize its network.

Bezdek stated that by giving consumers the option to provide GoodRx with more information, will raise the lifetime value (LTV) of each user’s prescription transactions as well as other areas. With an even more appealing GoodRx value proposition and user experience, Bezdek stated, “We believe the advantages of deeper relationships with our consumers will allow us to assist them better manage their healthcare journey.”

Bezdek then asserted that GoodRx now receives 30% of its revenue from non-core offerings, up from only 55% three years ago, and that subscription revenues have increased 82% from the prior year as a result of a significant increase in the number of members who upgraded to Gold accounts at a higher cost.